GHS targets 164,525 people for river blindness treatment campaign 

By Godfred Aaneamenga Polkuu, GNA 

Bolgatanga, Nov. 13, GNA – The Upper East Regional Health Directorate of the Ghana Health Service (GHS) has targeted 164,525 people for treatment under the second round of the 2026 Mass Drug Administration (MDA) campaign against onchocerciasis, commonly known as river blindness. 

The exercise, scheduled from November 15 to 28, 2026, will be conducted in four districts: Bawku West, Builsa South, Kassena-Nankana West and Tempane. Fourteen sub-districts in those areas have been identified as being at risk of the disease. 

Dr Braimah Baba Abubakari, Upper East Regional Director of the GHS, announced this at a media engagement in Bolgatanga aimed at briefing journalists on the campaign and soliciting their support for its successful implementation. 

He said out of an estimated 205,656 people at risk of the disease in the region, 164,525 had been targeted to receive ivermectin tablets through a house-to-house distribution strategy. 

“Trained health workers and community volunteers will visit homes and communities to distribute the medicines to eligible individuals,” he said. 

Dr Abubakari explained that onchocerciasis was a parasitic disease caused by Onchocerca volvulus and transmitted through the bites of infected blackflies that breed in fast-flowing rivers and streams. 

He noted that the disease could lead to intense itching, skin changes, including hypopigmentation commonly known as “leopard skin”, and blindness, making its prevention and elimination a public health priority. 

The Regional Director said onchocerciasis remained the second leading cause of preventable blindness globally and that the GHS continued to implement mass drug administration with ivermectin as its main elimination strategy, complemented by public health education. 

He explained that MDA involved the distribution of safe and effective medicines to eligible residents in endemic communities to interrupt disease transmission, reduce morbidity and prevent disabilities such as blindness. 

Dr Abubakari said the nationwide campaign would be implemented in 15 regions and 86 districts, with about 6.3 million people expected to benefit from the intervention. 

He stressed that achieving high treatment coverage was critical to interrupting disease transmission and ultimately eliminating river blindness from affected communities. 

However, he cautioned that not everyone was eligible to receive ivermectin tablets. Excluded groups include pregnant women, children below 90 centimetres in height, breastfeeding mothers with babies less than one week old, and severely ill persons. 

He urged all eligible residents to take the medicine as directed by trained distributors and assured the public that ivermectin was safe when administered according to the recommended guidelines. 

He further encouraged beneficiaries to report any adverse drug reactions to Community-Based Drug Distributors (CDDs) or the nearest health facility for prompt attention. 

On community participation, Dr Abubakari appealed to media practitioners, religious leaders, traditional authorities and Assembly Members in beneficiary communities to support public education, mobilisation and monitoring efforts. 

“All eligible individuals in the beneficiary communities are strongly encouraged to participate fully in the second round of the Onchocerciasis Mass Drug Administration campaign. Taking the medicines as directed is an important step towards preventing avoidable blindness and eliminating river blindness from our communities,” he said. 

The Regional Director acknowledged the support of the GHS, the National Neglected Tropical Diseases Programme, NOORDUBAI, the main sponsor of the second round of the campaign, as well as regional and district health teams, community volunteers and participating communities. 

Neglected Tropical Diseases (NTDs) are a group of infectious diseases that disproportionately affect poor and vulnerable populations, particularly those in rural and underserved communities. 

Ghana is endemic to 14 of the 21 NTDs identified by the World Health Organisation. In the Upper East region, prevalent NTDs include onchocerciasis, leprosy, yaws, elephantiasis, schistosomiasis, soil-transmitted helminthiasis, rabies and scabies. 

GNA 

Edited by Caesar Abagali/Lydia Kukua Asamoah